Cardiovascular risk assessment in patients with antiphospholipid syndrome: a cross-sectional performance analysis of nine clinical risk prediction tools.
George C DrososGeorge KonstantonisPetros P SfikakisMaria G G TektonidouPublished in: RMD open (2023)
Clinical CVR prediction tools underestimate actual high ASCVR in APS. VUS may help to improve CVR assessment and optimal risk factor management.